MFC Co., Ltd. (KRX:432980)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,620.00
+5.00 (0.14%)
At close: Dec 5, 2025
Market Cap 31.10B
Revenue (ttm) 20.17B
Net Income (ttm) -1.19B
Shares Out 8.59M
EPS (ttm) -151.59
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,417
Average Volume 15,616
Open 3,665.00
Previous Close 3,615.00
Day's Range 3,520.00 - 3,665.00
52-Week Range 3,190.00 - 8,440.00
Beta n/a
RSI 49.75
Earnings Date n/a

About MFC Co., Ltd.

MFC Co., Ltd. operates as a pharmaceutical company in South Korea. It specializes in research and development of pharmaceuticals; and provides APIs, pharmaceutical intermediates, Pd catalyst, and custom manufacturing services. The company was incorporated in 2008 and is based in Hwaseong-si, South Korea. [Read more]

Industry Non-operating Establishments
Founded 2008
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 432980
Full Company Profile

Financial Performance

In 2024, MFC Co., Ltd.'s revenue was 20.60 billion, an increase of 19.04% compared to the previous year's 17.31 billion. Losses were -1.18 billion, 63.9% more than in 2023.

Financial Statements

News

There is no news available yet.